Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.
Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.
复制标题
DOI:
10.1159/000381830
复制
发表时间:
2015
影响因子:
4.1
通讯作者:
Padmanabhan V
中科院分区:
文献类型:
--
作者:
Cardoso RC;Puttabyatappa M;Padmanabhan V
The susceptibility of the reproductive system to early exposure to steroid hormones has become a major concern in our modern societies. Human fetuses are at risk of abnormal programming via exposure to endocrine disrupting chemicals, inadvertent use of contraceptive pills during pregnancy, as well as from excess exposure to steroids through disease states. Animal models provide an unparalleled resource to understand the developmental origin of diseases. In female sheep, prenatal exposure to testosterone (T) excess results in an array of adult reproductive disorders that recapitulate those seen in women with polycystic ovary syndrome (PCOS), including disrupted neuroendocrine feedback mechanisms, increased pituitary sensitivity to gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH) excess, functional hyperandrogenism, and multifollicular ovarian morphology culminating in early reproductive failure. Prenatal T-treatment also leads to fetal growth retardation, insulin resistance, and hypertension. Mounting evidence suggests that developmental exposure to improper steroidal as well as metabolic environment may mediate the programming of adult disorders in prenatal T-treated females and these defects are maintained or amplified by postnatal sex steroid and metabolic milieu. This review addresses the steroidal and metabolic contributions to the development and maintenance of PCOS phenotype in the prenatal T-treated sheep model, centering specifically on the effects of prenatal and postnatal treatment with androgen antagonist or insulin sensitizer as potential strategies to prevent/ameliorate these dysfunctions. Insights obtained from these intervention strategies on the mechanisms underlying these defects are likely to have translational relevance to human PCOS.